Prelude Capital Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,240
Closed -$424K – 1467
2026
Q2
$424K Buy
+12,240
New +$329K 0.03% 598
2025
Q2
– Sell
-14,795
Closed -$437K – 1142
2025
Q1
$437K Sell
14,795
-2,009
-12% -$74.6K 0.03% 557
2024
Q4
$406K Buy
16,804
+1,832
+12% +$45.4K 0.03% 664
2024
Q3
$276K Buy
14,972
+3,858
+35% +$69.1K 0.02% 908
2024
Q2
$224K Sell
11,114
-7,404
-40% -$123K 0.02% 936
2024
Q1
$286K Buy
+18,518
New +$209K 0.02% 919
2021
Q2
– Sell
-12,542
Closed -$166K – 1775
2021
Q1
$166K Buy
+12,542
New +$210K ﹤0.01% 1362

Other funds holding HIMS

Prelude Capital Management's HIMS Position: Q3 2026 in Review

Prelude Capital Management sold out of Hims & Hers Health (HIMS) in Q3 2026, closing a stake of 12,240 shares — an estimated $424K sold.

Prelude Capital Management first reported a position in HIMS in Q1 2021 and held it in 7 quarters. The position peaked at $437K in Q1 2025. 475 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Prelude Capital Management reported no remaining Hims & Hers Health position as of Q3 2026 after selling out during the quarter.
  • Prelude Capital Management sold 12,240 Hims & Hers Health shares in Q3 2026, an estimated $424K.
  • Prelude Capital Management first reported a position in Hims & Hers Health in Q1 2021 and held it in 7 quarters.
  • Prelude Capital Management's Hims & Hers Health position peaked at $437K in Q1 2025.
  • 475 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.